ERGO's Legacy - Projects & Initiatives

ERGO closed in June 2024 but partners are ensuring its legacy continues beyond the project, specifically through their involvement in new projects and ongoing initiatives that will progress the research developed within ERGO, these include:  


As members of the below international expert, advisory, reference and working groups on endocrine disruptor research, ERGO partners will also carry on the project’s legacy, communicating the cross-vertebrate class testing approach to the OECD as well as the national and international entities involved in the OECD Test Guideline Work Programme (TGP).